Works matching IS 1744-9979 AND VI 26 AND DT 2022

Results: 206

Issue Information.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 1, doi. 10.1111/1744-9987.13669
Publication type:: Article

The development of lipoprotein apheresis in Saxony in the last years.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 53, doi. 10.1111/1744-9987.13940

By:

Kuss, Solveig Frieda Rosa;
Schatz, Ulrike;
Tselmin, Sergey;
Fischer, Sabine;
Julius, Ulrich

Publication type:

Article

Repeated lipoprotein apheresis and immune response: Effects on different immune cell populations.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 18, doi. 10.1111/1744-9987.13886

By:

Walther, Romy;
Wehner, Rebekka;
Tunger, Antje;
Julius, Ulrich;
Schatz, Ulrike;
Tselmin, Sergey;
Bornstein, Stefan R.;
Schmitz, Marc;
Graessler, Juergen

Publication type:

Article

Immunoadsorption and plasmapheresis at the ICU – A description of the frequencies and indications in a single center experience and a case report.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 97, doi. 10.1111/1744-9987.13865

By:

Koball, Sebastian;
Rogge, Johannes;
Frimmel, Silvius;
Hinz, Michael;
Mitzner, Steffen

Publication type:

Article

Beyond cholesterol—pleiotropic effects of lipoprotein apheresis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 35, doi. 10.1111/1744-9987.13857

By:

Schettler, Volker J. J.;
Schettler, Elke

Publication type:

Article

Issue Information.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 1, doi. 10.1111/1744-9987.13669
Publication type:: Article

Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 12, doi. 10.1111/1744-9987.13856

By:

Duell, Paul Barton;
Warden, Bruce A.

Publication type:

Article

A familial hypercholesterolemia registry as the main tool for adequate management of the disease.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 73, doi. 10.1111/1744-9987.13848

By:

Korneva, Victoria Alekseevna;
Kuznetsova, Tatiana Yurievna;
Julius, Ulrich

Publication type:

Article

Pregnancy in homozygous familial hypercholesterolemia—A case series.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 89, doi. 10.1111/1744-9987.13841

By:

Bláha, Milan;
Veletová, Kateřina;
Blaha, Vladimír;
Lánská, Miriam;
Žák, Pavel

Publication type:

Article

Therapeutic apheresis in sepsis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 64, doi. 10.1111/1744-9987.13815

By:

Klinkmann, Gerd;
Altrichter, Jens;
Reuter, Daniel A.;
Mitzner, Steffen

Publication type:

Article

Therapeutic plasma exchange in the intensive care unit: Rationale, special considerations, and techniques for combined circuits.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 41, doi. 10.1111/1744-9987.13814

By:

Sanchez, Amber P.;
Ward, David M.;
Cunard, Robyn

Publication type:

Article

Induction of vascular endothelial growth factor‐A<sub>165a</sub> in human retinal and endothelial cells in response to glyoxal.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 29, doi. 10.1111/1744-9987.13803

By:

Morawietz, Henning;
Frenzel, Annika;
Mieting, Alice;
Goettsch, Winfried;
Valtink, Monika;
Roehlecke, Cora;
Jászai, József;
Funk, Richard H. W.;
Becker, Klio A.;
Engelmann, Katrin

Publication type:

Article

The German Lipoprotein Apheresis Registry—Summary of the ninth annual report.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 81, doi. 10.1111/1744-9987.13780

By:

Schettler, Volker J. J.;
Peter, Christian;
Zimmermann, Thomas;
Julius, Ulrich;
Roeseler, Eberhard;
Schlieper, Georg;
Heigl, Franz;
Grützmacher, Peter;
Löhlein, Iris;
Klingel, Reinhard;
Hohenstein, Bernd;
Ramlow, Wolfgang;
Vogt, Anja

Publication type:

Article

Use of therapeutic plasma exchange in COVID‐19: A systematic review of current evidence.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, p. 3, doi. 10.1111/1744-9987.13779

By:

Carlson, Nicholas;
Szpirt, Wladimir M.

Publication type:

Article

Discordance between hemodialysis patients' reports and their physicians' estimates of adherence to dietary restrictions in Japan.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1156, doi. 10.1111/1744-9987.13852

By:

Sugisawa, Hidehiro;
Shimizu, Yumiko;
Kumagai, Tamaki;
Shinoda, Toshio;
Shishido, Kanji;
Koda, Yutaka

Publication type:

Article

Particulates formed in online prepared substitution fluid—Effect of acetic acid cleaning on endotoxin retentive filters.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1193, doi. 10.1111/1744-9987.13851

By:

Imai, Motoyuki;
Yamamoto, Masahito;
Togo, Konomi;
Yamashita, Akihiro C.

Publication type:

Article

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta‐analysis of randomized controlled trials.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1086, doi. 10.1111/1744-9987.13850

By:

Li, Rui;
Gao, Xiang;
Zhou, Tao;
Li, Yunjie;
Wang, Jianhui;
Zhang, Peirong

Publication type:

Article

Low‐density lipoprotein and blood pressure are important risk factors for vasculopathy in children on dialysis: A single center study.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1220, doi. 10.1111/1744-9987.13846

By:

Conkar Tunçay, Seçil;
Keskinoğlu, Ahmet;
Bulut, İpek Kaplan;
Levent, Ertürk;
Hakverdi, Gülden;
Kabasakal, Caner

Publication type:

Article

Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1274, doi. 10.1111/1744-9987.13844

By:

Gonzalez, Camilo;
Vargas, Diana;
Contreras, Kateir;
Garcia, Paola;
Rodriguez, Patricia;
Zarco, Luis;
Navas, Carlos

Publication type:

Article

Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV‐2 antibodies.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1289, doi. 10.1111/1744-9987.13842

By:

Bertram, Sebastian;
Pfab, Thiemo;
Albert, Christian;
Schmidt, Sven;
Passfall, Jürgen;
Haesner, Martin;
Seidel, Maximilian;
Hölzer, Bodo;
Seibert, Felix S.;
Doevelaar, Adrian;
Rohn, Benjamin;
Zgoura, Panagiota;
Babel, Nina;
Westhoff, Timm H.

Publication type:

Article

Comparison of plasma separation using centrifugation or filtration for MONET lipoprotein apheresis in patients with cardiovascular disease and severe dyslipidemia.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1281, doi. 10.1111/1744-9987.13840

By:

Waitz, Grit;
Atiye, Saynab;
Gauly, Adelheid;
Prophet, Heinrich

Publication type:

Article

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1065, doi. 10.1111/1744-9987.13839

By:

Nangaku, Masaomi;
Akizawa, Tadao;
Nagakubo, Takashi;
Yonekawa, Taeko;
Kimura, Toshifumi;
Endo, Yukihiro;
Cobitz, Alexander

Publication type:

Article

Sociodemographic features and outcomes of peritonitis episodes in children on peritoneal dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1264, doi. 10.1111/1744-9987.13836

By:

Pınarbaşı, Ayşe Seda;
Akbalık Kara, Mehtap

Publication type:

Article

Peri‐dialytic hypoglycemia with hemodialysis and online post‐dilutional hemodiafiltration.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1148, doi. 10.1111/1744-9987.13835

By:

Davenport, Andrew

Publication type:

Article

Screening for Fabry disease among male patients on hemodialysis in Awaji Island.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1187, doi. 10.1111/1744-9987.13834

By:

Shimizu, Mao;
Fujii, Hideki;
Kono, Keiji;
Watanabe, Kentaro;
Goto, Shunsuke;
Nozu, Kandai;
Nakamura, Kimitoshi;
Nishi, Shinichi

Publication type:

Article

The association between serum cystatin C and residual renal function in peritoneal dialysis patients.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1241, doi. 10.1111/1744-9987.13832

By:

Zhang, Suojian;
Li, Haitao;
Cai, Xiaoqin;
Zhao, Caixia;
Cao, Juan

Publication type:

Article

Nutritional potassium limitation impact on serum potassium change, and death in chronic kidney disease: A meta‐analysis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1079, doi. 10.1111/1744-9987.13831

By:

Gong, Zhumei;
Chen, Taiai

Publication type:

Article

Causes and risk factors for peritoneal dialysis withdrawal.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1256, doi. 10.1111/1744-9987.13809

By:

Wu, Yanni;
Yao, Yu;
Liu, Li;
Shen, Xiaoying;
Yang, He;
Zhang, Tiewei

Publication type:

Article

A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1182, doi. 10.1111/1744-9987.13818

By:

Koc, Neriman Sila;
Yildirim, Tolga;
Girgin, Sinem;
Onal, Ceren;
Tahillioglu, Yagmur;
Yilmaz, Rahmi;
Arici, Mustafa;
Altun, Bulent;
Erdem, Yunus

Publication type:

Article

Correction of severe hyponatremia by continuous veno‐venous hemodialysis with regional citrate anticoagulation: A case series.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1114, doi. 10.1111/1744-9987.13808

By:

Ling, Kin Ho Steven;
Wu, Ping;
Chan, King‐Chung

Publication type:

Article

Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1174, doi. 10.1111/1744-9987.13813

By:

Nagano, Nobuo;
Fukushima, Takahiro;
Shikata, Risa;
Ando, Tetsuo;
Tsutsui, Takaaki;
Ogawa, Tetsuya;
Ito, Kyoko

Publication type:

Article

Clinical features and risk factors associated with mortality in critically ill children requiring continuous renal replacement therapy.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1121, doi. 10.1111/1744-9987.13811

By:

Duyu, Muhterem;
Turkozkan, Ceren

Publication type:

Article

Association between lipid profile and residual renal function in incident peritoneal dialysis patients.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1235, doi. 10.1111/1744-9987.13821

By:

Honda, Yu;
Maruyama, Yukio;
Nakamura, Mami;
Nakao, Masatsugu;
Matsuo, Nanae;
Tanno, Yudo;
Ohkido, Ichiro;
Ikeda, Masato;
Yokoo, Takashi

Publication type:

Article

The prevalence and severity of mental health problems and sexual dysfunction in hemodialysis patients before and during the COVID‐19 pandemic.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1211, doi. 10.1111/1744-9987.13805

By:

Duru, Huseyin

Publication type:

Article

Association of serum potassium derangements with mortality among patients requiring continuous renal replacement therapy.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1098, doi. 10.1111/1744-9987.13804

By:

Thongprayoon, Charat;
Cheungpasitporn, Wisit;
Radhakrishnan, Yeshwanter;
Zabala Genovez, Jose L.;
Petnak, Tananchai;
Shawwa, Khaled;
Qureshi, Fawad;
Mao, Michael A.;
Kashani, Kianoush B.

Publication type:

Article

Prognostic risk factors in patients with refractory heart failure treated with continuous veno‐venous hemofiltration.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1106, doi. 10.1111/1744-9987.13812

By:

Mao, Zhengzhi;
Zhong, Yanyan

Publication type:

Article

Effects of aromatherapy massage on the severity of restless legs syndrome in hemodialysis patients: A randomized clinical trial.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1131, doi. 10.1111/1744-9987.13802

By:

Amrollahi, Akram;
Rafiei, Amirreza;
Bahri, Ahdie;
Nasiriani, Khadijeh

Publication type:

Article

YouTube as a source of information on COVID‐19 and dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1202, doi. 10.1111/1744-9987.13801

By:

Akyol Onder, Esra Nagehan;
Ertan, Pelin

Publication type:

Article

Influence of continuity of care on self‐management ability and quality of life in outpatient maintenance hemodialysis patients.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1166, doi. 10.1111/1744-9987.13800

By:

Lai, Bihong;
Shen, Li;
Ye, Shuiying;
Shen, Xia;
Zhou, Dongchi;
Guo, Xiaocui;
Zhou, Huaxian;
Pan, Yangbin;
Tong, Jindong

Publication type:

Article

Predictive role of fluctuating biochemical parameters for mortality in hemodialysis patients.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1137, doi. 10.1111/1744-9987.13798

By:

Mülling, Nils;
ter Huurne, Jan;
Kahl, Anna Lena;
Tokmak, Faruk;
Spitthöver, Ralf;
Kribben, Andreas;
Reinhardt, Walter

Publication type:

Article

Clinical feasibility of transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis: A prospective multicenter study in Japan.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1226, doi. 10.1111/1744-9987.13796

By:

Maruyama, Yukio;
Yokoyama, Keitaro;
Higuchi, Chieko;
Sanaka, Tsutomu;
Tanaka, Yoshihide;
Sakai, Ken;
Kanno, Yoshihiko;
Ryuzaki, Munekazu;
Sakurada, Tsutomu;
Hosoya, Tatsuo;
Nakayama, Masaaki

Publication type:

Article

Adverse effects of iron toward the peritoneal mesothelial cells are reversible.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1247, doi. 10.1111/1744-9987.13797

By:

Jasiński, Tomasz;
Bręborowicz, Andrzej

Publication type:

Article

Predictors of mortality in COVID‐19 induced acute kidney injury.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 5, p. 897, doi. 10.1111/1744-9987.13895

By:

Yüksel, Enver;
Arac, Songül;
Deniz Altintaş, Derya

Publication type:

Article

Evaluation of the relationship between COVID‐19 anxiety and treatment compliance in hemodialysis patients: A prospective, descriptive study.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 5, p. 977, doi. 10.1111/1744-9987.13893

By:

Terkes, Nurten;
Okten, Ciğdem

Publication type:

Article

Therapeutic Apheresis and Dialysis Forthcoming Events December 2022.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1296, doi. 10.1111/1744-9987.13682
Publication type:: Article

Evaluation of psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors among hemodialysis patients in the COVID‐19 pandemic.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 5, p. 941, doi. 10.1111/1744-9987.13905
Publication type:: Article

Corporate Members.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1297, doi. 10.1111/1744-9987.13683
Publication type:: Article

Issue Information.

Published in:: Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1063, doi. 10.1111/1744-9987.13684
Publication type:: Article

Actual rates of electricity consumption in blood purification modalities.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 5, p. 1058, doi. 10.1111/1744-9987.13888

By:

Nagai, Kei;
Nakamura, Yoshiharu

Publication type:

Article

Efficacy of monotherapy with low‐density lipoprotein apheresis for severe renal disorder caused by cholesterol crystal embolization: A case report.

Published in:

Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 5, p. 1056, doi. 10.1111/1744-9987.13863

By:

Yoshida, Noriyo;
Shimozato, Seiji;
Wada, Yukihiro

Publication type:

Article